Blonde L - Search Results

1

Comparison of vildagliptin and thiazolidinedione as add-on therapy in patients inadequately controlled with metformin: results of the GALIANT trial--a primary care, type 2 diabetes study.

Blonde L, Dagogo-Jack S, Banerji MA, Pratley RE, Marcellari A, Braceras R, Purkayastha D, Baron M. Blonde L, et al. Diabetes Obes Metab. 2009 Oct;11(10):978-86. doi: 10.1111/j.1463-1326.2009.01080.x. Epub 2009 Jul 13. Diabetes Obes Metab. 2009. PMID: 19614942 Clinical Trial.

2

Glyburide/metformin combination product is safe and efficacious in patients with type 2 diabetes failing sulphonylurea therapy.

Blonde L, Rosenstock J, Mooradian AD, Piper BA, Henry D. Blonde L, et al. Diabetes Obes Metab. 2002 Nov;4(6):368-75. doi: 10.1046/j.1463-1326.2002.00229.x. Diabetes Obes Metab. 2002. PMID: 12406033 Clinical Trial.

3

Thiazolidinediones in the treatment of managed care patients with type 2 diabetes.

Pathak R, Afaq A, Blonde L. Pathak R, et al. Among authors: blonde l. Am J Manag Care. 2002 Oct;8(16 Suppl):S483-94. Am J Manag Care. 2002. PMID: 12408411 Free article. Review.

4

Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance) in type 2 diabetes.

Garber A, Marre M, Blonde L, Allavoine T, Howlett H, Lehert P, Cornes M. Garber A, et al. Among authors: blonde l. Diabetes Obes Metab. 2003 May;5(3):171-9. doi: 10.1046/j.1463-1326.2003.00259.x. Diabetes Obes Metab. 2003. PMID: 12681024

5

Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin.

Blonde L, Wogen J, Kreilick C, Seymour AA. Blonde L, et al. Diabetes Obes Metab. 2003 Nov;5(6):424-31. doi: 10.1046/j.1463-1326.2003.00297.x. Diabetes Obes Metab. 2003. PMID: 14617228

6

Durable efficacy of metformin/glibenclamide combination tablets (Glucovance) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia despite previous sulphonylurea monotherapy.

Blonde L, Joyal S, Henry D, Howlett H. Blonde L, et al. Int J Clin Pract. 2004 Sep;58(9):820-6. doi: 10.1111/j.1742-1241.2004.00316.x. Int J Clin Pract. 2004. PMID: 15529514 Clinical Trial.

7

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes.

Blonde L, Klein EJ, Han J, Zhang B, Mac SM, Poon TH, Taylor KL, Trautmann ME, Kim DD, Kendall DM. Blonde L, et al. Diabetes Obes Metab. 2006 Jul;8(4):436-47. doi: 10.1111/j.1463-1326.2006.00602.x. Diabetes Obes Metab. 2006. PMID: 16776751 Clinical Trial.

8

State of diabetes care in the United States.

Blonde L. Blonde L. Am J Manag Care. 2007 Apr;13 Suppl 2:S36-40. Am J Manag Care. 2007. PMID: 17417931 Free article. Review.

9

Case presentation: a patient with type 2 diabetes.

Blonde L, Haines ST, Leahy JJ, Siminerio L. Blonde L, et al. Diabetes Educ. 2007 May-Jun;33 Suppl 5:114S-6S; quiz 117S. doi: 10.1177/0145721707302S888. Diabetes Educ. 2007. PMID: 17548899 No abstract available.

10

Easing the transition to insulin therapy in people with type 2 diabetes.

Blonde L. Blonde L. Diabetes Educ. 2007 Jul-Aug;33 Suppl 7:232S-240S. doi: 10.1177/0145721707305695. Diabetes Educ. 2007. PMID: 17656739 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page